Rxsight Inc
RXST10.930USD
-0.530-4.62%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
449.02MMarket Cap
LossP/E TTM
More Details of Rxsight Inc Company
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Rxsight Inc Info
Ticker SymbolRXST
Company nameRxsight Inc
IPO dateJul 30, 2021
CEOKurtz (Ron M)
Number of employees498
Security typeOrdinary Share
Fiscal year-endJul 30
Address100 Columbia Street
CityALISO VIEJO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92656
Phone19495217822
Websitehttps://www.rxsight.com/
Ticker SymbolRXST
IPO dateJul 30, 2021
CEOKurtz (Ron M)
Company Executives of Rxsight Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+60.99%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
67.06K
+53.75%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+22.24%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+35.50%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-1.26%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+145.63%
Dr. Ron M. Kurtz, M.D.
Dr. Ron M. Kurtz, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Mr. J. Andy Corley
Mr. J. Andy Corley
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+60.99%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
67.06K
+53.75%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+22.24%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+35.50%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-1.26%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+145.63%
Revenue Breakdown
FY2024
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
139.93M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
5.47%
Millennium Management LLC
5.33%
The Vanguard Group, Inc.
5.22%
D. E. Shaw & Co., L.P.
4.46%
Artisan Partners Limited Partnership
4.27%
Other
75.25%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
5.47%
Millennium Management LLC
5.33%
The Vanguard Group, Inc.
5.22%
D. E. Shaw & Co., L.P.
4.46%
Artisan Partners Limited Partnership
4.27%
Other
75.25%
Shareholder Types
Shareholders
Proportion
Investment Advisor
34.73%
Hedge Fund
24.74%
Investment Advisor/Hedge Fund
13.27%
Research Firm
7.17%
Individual Investor
5.59%
Pension Fund
1.07%
Private Equity
0.56%
Bank and Trust
0.28%
Family Office
0.06%
Other
12.53%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
449
38.67M
94.05%
-9.26M
2025Q2
446
40.83M
100.45%
-3.67M
2025Q1
453
40.49M
99.79%
-7.96M
2024Q4
440
38.96M
96.23%
-5.07M
2024Q3
420
38.15M
94.75%
-3.92M
2024Q2
391
37.00M
93.42%
-2.64M
2024Q1
338
34.63M
93.15%
-2.60M
2023Q4
299
33.17M
91.51%
-284.01K
2023Q3
253
34.41M
96.36%
-1.84M
2023Q2
214
31.39M
90.12%
+2.22M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
2.51M
6.13%
-48.31K
-1.89%
Jun 30, 2025
Millennium Management LLC
2.61M
6.38%
+1.66M
+174.50%
Jul 09, 2025
The Vanguard Group, Inc.
2.27M
5.55%
-113.59K
-4.76%
Jun 30, 2025
D. E. Shaw & Co., L.P.
1.32M
3.23%
+1.30M
+5906.05%
Jun 30, 2025
Artisan Partners Limited Partnership
2.25M
5.51%
+485.02K
+27.44%
Jun 30, 2025
NO STREET GP LP
1.20M
2.93%
+600.00K
+100.00%
Jun 30, 2025
Two Sigma Investments, LP
621.86K
1.52%
+408.47K
+191.42%
Jun 30, 2025
Citadel Advisors LLC
1.03M
2.51%
+797.64K
+346.47%
Jun 30, 2025
DWS Investments UK Limited
1.22M
2.99%
+566.62K
+86.54%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
0.62%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
iShares Morningstar Small-Cap Value ETF
0.01%
iShares Russell 2000 ETF
0.01%
WisdomTree US SmallCap Fund
0.01%
Schwab U.S. Small-Cap ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion0.62%
ProShares Hedge Replication ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.02%
iShares Morningstar Small-Cap Value ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
WisdomTree US SmallCap Fund
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Rxsight Inc?
The top five shareholders of Rxsight Inc are:
BlackRock Institutional Trust Company, N.A. holds 2.51M shares, accounting for 6.13% of the total shares.
Millennium Management LLC holds 2.61M shares, accounting for 6.38% of the total shares.
The Vanguard Group, Inc. holds 2.27M shares, accounting for 5.55% of the total shares.
D. E. Shaw & Co., L.P. holds 1.32M shares, accounting for 3.23% of the total shares.
Artisan Partners Limited Partnership holds 2.25M shares, accounting for 5.51% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.51M shares, accounting for 6.13% of the total shares.
Millennium Management LLC holds 2.61M shares, accounting for 6.38% of the total shares.
The Vanguard Group, Inc. holds 2.27M shares, accounting for 5.55% of the total shares.
D. E. Shaw & Co., L.P. holds 1.32M shares, accounting for 3.23% of the total shares.
Artisan Partners Limited Partnership holds 2.25M shares, accounting for 5.51% of the total shares.
What are the top three shareholder types of Rxsight Inc?
The top three shareholder types of Rxsight Inc are:
BlackRock Institutional Trust Company, N.A.
Millennium Management LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Millennium Management LLC
The Vanguard Group, Inc.
How many institutions hold shares of Rxsight Inc (RXST)?
As of 2025Q3, 449 institutions hold shares of Rxsight Inc, with a combined market value of approximately 38.67M, accounting for 94.05% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -6.40%.
What is the biggest source of revenue for Rxsight Inc?
In FY2024, the -- business generated the highest revenue for Rxsight Inc, amounting to -- and accounting for --% of total revenue.
